| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JMB.2006.11.073 |
| P8608 | Fatcat ID | release_3tldsp2e7jex5bzcjkwcrk3zqi |
| P932 | PMC publication ID | 7094453 |
| P698 | PubMed publication ID | 17189639 |
| P5875 | ResearchGate publication ID | 6610241 |
| P50 | author | Rao Zihe | Q9030008 |
| Xiaoyu Xue | Q114725826 | ||
| Mark Bartlam | Q28037033 | ||
| Kailin Yang | Q37366543 | ||
| Cheng Chen | Q66680488 | ||
| Haitao Yang | Q66680517 | ||
| P2093 | author name string | Jun Li | |
| Qi Zhao | |||
| Wei Shen | |||
| Yinghua Jin | |||
| P2860 | cites work | Design of wide-spectrum inhibitors targeting coronavirus main proteases | Q24817106 |
| Processing of X-ray diffraction data collected in oscillation mode | Q26778468 | ||
| Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes | Q27619756 | ||
| Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs | Q27641252 | ||
| The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor | Q27642450 | ||
| Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase | Q27860571 | ||
| On the size of the active site in proteases. I. Papain | Q27860826 | ||
| Coronavirus as a possible cause of severe acute respiratory syndrome | Q28200848 | ||
| Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency | Q28216587 | ||
| A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site | Q29615285 | ||
| Identification of a novel coronavirus in patients with severe acute respiratory syndrome | Q29615907 | ||
| A novel coronavirus associated with severe acute respiratory syndrome | Q29617553 | ||
| Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein | Q30194279 | ||
| Myo-inositol monophosphatase is an activated target of calbindin D28k | Q30842869 | ||
| Protein production: feeding the crystallographers and NMR spectroscopists | Q34097108 | ||
| Aetiology: Koch's postulates fulfilled for SARS virus | Q34197103 | ||
| Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase | Q34270281 | ||
| The coronavirus replicase. | Q35989123 | ||
| Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer | Q35994898 | ||
| Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs | Q38336860 | ||
| Distribution of calretinin, calbindin D28k, and parvalbumin in subcellular fractions of rat cerebellum: effects of calcium | Q39757626 | ||
| pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses | Q43919382 | ||
| 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism | Q44839752 | ||
| Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. | Q44861300 | ||
| High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase | Q45110672 | ||
| Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay. | Q45118974 | ||
| Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations | Q45126666 | ||
| Differential effects of short affinity tags on the crystallization of Pyrococcus furiosus maltodextrin-binding protein | Q45714169 | ||
| Mechanism of the maturation process of SARS-CoV 3CL protease | Q46402178 | ||
| Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. | Q46438629 | ||
| Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. | Q46747607 | ||
| Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease | Q47893269 | ||
| Distribution of calretinin, calbindin-D28k and parvalbumin in the hypothalamus of the squirrel monkey | Q48513807 | ||
| Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex | Q48596760 | ||
| Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. | Q51660929 | ||
| Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates | Q55062524 | ||
| Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate | Q69868276 | ||
| Study of the Specificity of Thrombin with Tripeptidyl-p-nitroanilide Substrates | Q70792857 | ||
| Efficient and rapid affinity purification of proteins using recombinant fusion proteases | Q72273451 | ||
| A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates | Q73820226 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | structural biology | Q908902 |
| 3C-like proteinase [SARS-Cov] | Q89455671 | ||
| SARS-CoV-1 | Q85438966 | ||
| P304 | page(s) | 965-75 | |
| P577 | publication date | 2007-02-23 | |
| P1433 | published in | Journal of Molecular Biology | Q925779 |
| P1476 | title | Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction | |
| P478 | volume | 366 |
| Q43720745 | 1H, 13C and 15N resonance assignments of SARS-CoV main protease N-terminal domain |
| Q36673223 | A novel mutation in murine hepatitis virus nsp5, the viral 3C-like proteinase, causes temperature-sensitive defects in viral growth and protein processing |
| Q27650857 | A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters |
| Q37870810 | Activation and maturation of SARS-CoV main protease |
| Q100960135 | An Overview of the Crystallized Structures of the SARS-CoV-2 |
| Q50483332 | Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins. |
| Q104495290 | Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2 |
| Q98951985 | Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease |
| Q30155962 | Characterization of Bafinivirus main protease autoprocessing activities |
| Q37336376 | Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity |
| Q36583222 | Conformational Flexibility of a Short Loop near the Active Site of the SARS-3CLpro is Essential to Maintain Catalytic Activity. |
| Q46753157 | Correlation between dissociation and catalysis of SARS-CoV main protease. |
| Q88219766 | Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors |
| Q34652825 | Crystallization and preliminary crystallographic study of Porcine epidemic diarrhea virus main protease in complex with an inhibitor |
| Q102152135 | Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site |
| Q37350479 | Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors |
| Q33921124 | Dynamically-driven enhancement of the catalytic machinery of the SARS 3C-like protease by the S284-T285-I286/A mutations on the extra domain |
| Q28477275 | Dynamically-driven inactivation of the catalytic machinery of the SARS 3C-like protease by the N214A mutation on the extra domain |
| Q43204921 | Engineering a novel endopeptidase based on SARS 3CL(pro). |
| Q36775883 | Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery. |
| Q26992345 | From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design |
| Q107138031 | Hallmarks of Alpha- and Betacoronavirus non-structural protein 7+8 complexes |
| Q35065902 | Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings |
| Q52666466 | Importance of homo-dimerization of Fanconi-associated nuclease 1 in DNA flap cleavage. |
| Q51916292 | In silico prediction of SARS protease inhibitors by virtual high throughput screening. |
| Q52621974 | Insights into DNA substrate selection by APOBEC3G from structural, biochemical, and functional studies. |
| Q41884048 | Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode |
| Q27649949 | Mechanism for Controlling the Dimer-Monomer Switch and Coupling Dimerization to Catalysis of the Severe Acute Respiratory Syndrome Coronavirus 3C-Like Protease |
| Q27684519 | Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease |
| Q111086158 | Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor |
| Q99624096 | Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2 |
| Q27648944 | Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations |
| Q38837369 | Over-expression, purification, and confirmation of Bacillus anthracis transcriptional regulator NprR. |
| Q27671833 | Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease |
| Q57022004 | Phosphoserine acidic cluster motifs bind distinct basic regions on the μ subunits of clathrin adaptor protein complexes |
| Q41189291 | Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus |
| Q89828199 | Processing of the SARS-CoV pp1a/ab nsp7-10 region |
| Q108395975 | Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease |
| Q37469524 | SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity. |
| Q97552375 | SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3 |
| Q111537474 | SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog |
| Q107272288 | Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2 |
| Q98775623 | Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2 |
| Q97905448 | Structural basis of CD4 downregulation by HIV-1 Nef |
| Q24297949 | Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1 |
| Q27681200 | Structural basis of evasion of cellular adaptive immunity by HIV-1 Nef |
| Q34453444 | Structural insights into 5' flap DNA unwinding and incision by the human FAN1 dimer |
| Q27656805 | Structure and cleavage specificity of the chymotrypsin-like serine protease (3CLSP/nsp4) of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) |
| Q89975279 | Structure of Mpro from COVID-19 virus and discovery of its inhibitors |
| Q87967188 | Structure of Mpro from COVID-19 virus and discovery of its inhibitors |
| Q27649375 | Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design |
| Q35592656 | Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity |
| Q35943856 | Temperature-sensitive mutants and revertants in the coronavirus nonstructural protein 5 protease (3CLpro) define residues involved in long-distance communication and regulation of protease activity |
| Q37760943 | The highly cited SARS research literature |
| Q27666447 | Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease |
| Q41780919 | Without its N-finger, the main protease of severe acute respiratory syndrome coronavirus can form a novel dimer through its C-terminal domain. |
| Q89654680 | α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment |
Search more.